ISSUE: 2001/06/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Previous Issue of Recent Publications (2001/04/a)

Next Issue of Recent Publications (2001/07/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Cooper R, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 2001 Jun;36(6):623-9    [Related articles]

Geoerger B, et al. Metabolic activity and clinical features of primary ganglioneuromas. Cancer 2001 May 15;91(10):1905-13    [Related articles]

Hoefnagel CA, et al. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med 2001 Mar;28(3):359-68    [Related articles]

Johnston DL, et al. Gastrointestinal Stromal Tumor in a Patient With Previous Neuroblastoma. Am J Pediatr Hematol Oncol 2001 May;23(4):255-256    [Related articles]

Kushner BH, et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 2001 Jun 1;19(11):2821-8    [Related articles]

Makimoto K, et al. Response bias by neuroblastoma screening participation status and social desirability bias in an anonymous postal survey, Ishikawa, Japan. J Epidemiol 2001 Mar;11(2):70-3    [Related articles]     Screening

Monsieurs MA, et al. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours. Nucl Med Commun 2001 Apr;22(4):367-74    [Related articles]

Reynolds CP, et al. Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma. J Pediatr Hematol Oncol 2001 Mar-Apr;23(3):150-2    [Related articles]

Rudnick E, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med Pediatr Oncol 2001 Jun;36(6):612-22    [Related articles]

Stern JW, et al. Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model. Clin Cancer Res 2001 Apr;7(4):1026-32    [Related articles]

Basic Science / Neuroblastoma Research

Beierle EA, et al. Vegf is upregulated in a neuroblastoma and hepatocyte coculture model. J Surg Res 2001 May;97(1):34-40    [Related articles]

Carlson K, et al. Human neuroblastoma cell viability and growth are affected by altered culture conditions. In Vitr Mol Toxicol 2000 Winter;13(4):249-62    [Related articles]

Coffey DC, et al. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res 2001 May 1;61(9):3591-4    [Related articles]

Engler S, et al. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies. Cancer Res 2001 Apr 1;61(7):2968-73    [Related articles]

Gaitanou M, et al. Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis. Biochem J 2001 May 1;355(Pt 3):715-24    [Related articles]     Chromosome 1p

Han S, et al. Differentiation of Human Neuroblastoma by Phenylacetate Is Mediated by Peroxisome Proliferator-activated Receptor gamma. Cancer Res 2001 May 15;61(10):3998-4002    [Related articles]

Iyengar RV, et al. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Res 2001 Apr 1;61(7):3045-52    [Related articles]     MYCN Amplification

Kim SN, et al. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 2001 Jul 1;93(1):33-41    [Related articles]

Michaelis M, et al. Treatment of drug-resistant human neuroblastoma cells with cyclodextrin inclusion complexes of aphidicolin. Anticancer Drugs 2001 Jun;12(5):467-473    [Related articles]

Mora J, et al. Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res 2001 May;7(5):1358-61    [Related articles]

Raguenez G, et al. A functional gene map is required to adapt therapy of metastatic neuroblastoma] Bull Cancer 2001 Mar;88(3):295-304    [Related articles]

Servidei T, et al. The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin. Eur J Cancer 2001 May;37(7):930-8    [Related articles]

Shusterman S, et al. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. Clin Cancer Res 2001 Apr;7(4):977-84    [Related articles]

Thompson J, et al. Development, characterization and therapy of a disseminated model of childhood neuroblastoma in SCID mice. Cancer Chemother Pharmacol 2001 Mar;47(3):211-21    [Related articles]

Tweddle DA, et al. p53 Cellular localization and function in neuroblastoma : evidence for defective g(1) arrest despite waf1 induction in mycn-amplified cells. Am J Pathol 2001 Jun;158(6):2067-77    [Related articles]     MYCN Amplification

Vettenranta K, et al. Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma. Cancer Genet Cytogenet 2001 Mar;125(2):125-30    [Related articles]

Wasa M, et al. Insulin-like growth factor-I stimulates amino acid transport in a glutamine-deprived human neuroblastoma cell line. Biochim Biophys Acta 2001 Feb 16;1525(1-2):118-24    [Related articles]

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Antony P, et al. Effect of retinoic acid on the Ca2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochem Res 2001 Jan;26(1):83-8    [Related articles]

Chen XL, et al. Overexpression of rat neuronal calcium sensor-1 in rodent NG108-15 cells enhances synapse formation and transmission. J Physiol 2001 May 1;532(Pt 3):649-59    [Related articles]

Giorgi M, et al. In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors. J Neurooncol 2001 Jan;51(1):25-31    [Related articles]

Johnson G, et al. Association of the HNK-1 epitope with the detergent-soluble G4 isoform of acetylcholinesterase from human neuroblastoma cells. Int J Dev Neurosci 2001 Jul;19(4):439-45    [Related articles]

Laub F, et al. Developmental expression of mouse kruppel-like transcription factor klf7 suggests a potential role in neurogenesis. Dev Biol 2001 May 15;233(2):305-18    [Related articles]

Rossi L, et al. Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis. Free Radic Biol Med 2001 May 15;30(10):1177-87    [Related articles]

Susulic VS, et al. Expression of the human beta(3)-adrenergic receptor gene in SK-N-MC cells is under the control of a distal enhancer. Endocrinology 2001 May;142(5):1935-49    [Related articles]

Webster NJ, et al. Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Brain Res Mol Brain Res 2001 Apr 18;89(1-2):50-7    [Related articles]

Previous Issue of Recent Publications (2001/04/a)
Next Issue of Recent Publications (2001/07/a)
Back to NBL-PROF Home Page